GlaxoSmithKline Pharmaceuticals Limited
GLAXO
주식 순위
#3644
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
주가
$27.54
마지막 동기화: 2026-10-19
시가총액
$4.67B
변동 (1일)
-2.73%
변동 (1년)
-12.13%
국가
IN
거래 GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
카테고리
Healthcare
GlaxoSmithKline Pharmaceuticals Limited (GLAXO)의 P/S 비율
October 2026 기준 P/S 비율 TTM: 10.72
GlaxoSmithKline Pharmaceuticals Limited의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 10.72입니다. 2024년 말 기준 P/S 비율은 9.74였습니다.
GlaxoSmithKline Pharmaceuticals Limited의 P/S 비율 기록 (2004 ~ 2026)
매년 말 P/S 비율
| 연도 | P/S 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | 10.72 | -15.16% |
| 2025 | 12.64 | 29.73% |
| 2024 | 9.74 | 41.17% |
| 2023 | 6.90 | -19.88% |
| 2022 | 8.61 | 3.26% |
| 2021 | 8.34 | 26.28% |
| 2020 | 6.61 | -6.14% |
| 2019 | 7.04 | 13.41% |
| 2018 | 6.21 | -22.36% |
| 2017 | 7.99 | -31.64% |
| 2016 | 11.69 | 6.32% |
| 2015 | 11.00 | 10.60% |
| 2013 | 9.94 | 43.71% |
| 2012 | 6.92 | -0.12% |
| 2011 | 6.93 | -24.74% |
| 2010 | 9.20 | 28.61% |
| 2009 | 7.16 | 24.35% |
| 2008 | 5.76 | 6.38% |
| 2007 | 5.41 | -12.92% |
| 2006 | 6.21 | -1.99% |
| 2005 | 6.34 | 32.89% |
| 2004 | 4.77 | 0.00% |
유사 기업 또는 경쟁사의 P/S 비율
| 회사 | P/S 비율 | P/S 비율 차이 | 국가 |
|---|---|---|---|
| 14.32 | 33.54% |
US
|
|
| 6.16 | -42.56% |
US
|
|
| 7.78 | -27.45% |
US
|
|
| 5.48 | -48.88% |
US
|
|
| 4.66 | -56.56% |
CH
|
